| Dr Aaron Todd Breit, MD | |
|
421 Andri Ct, El Dorado Hills, CA 95762-5231 | |
| (916) 969-8370 | |
| Not Available |
| Full Name | Dr Aaron Todd Breit |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 421 Andri Ct, El Dorado Hills, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528271046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A100795 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Of Folsom | Folsom, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
ev3 Inc., a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted for filing the company's Pre-Market Approval (PMA) application for the Pipeline Embolization Device for treatment of large, giant and wide-necked cerebral aneurysms. The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is May 18, 2010, the date the FDA received ev3's PMA submission.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody.
Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study published in the Journal of Infectious Diseases.
Cardiorespiratory fitness is associated with reduced metabolic syndrome risk among smokers, according to researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
› Verified 1 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
ev3 Inc., a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted for filing the company's Pre-Market Approval (PMA) application for the Pipeline Embolization Device for treatment of large, giant and wide-necked cerebral aneurysms. The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is May 18, 2010, the date the FDA received ev3's PMA submission.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody.
Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study published in the Journal of Infectious Diseases.
Cardiorespiratory fitness is associated with reduced metabolic syndrome risk among smokers, according to researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
› Verified 1 days ago
| Entity Name | Vituity - Urgent Care Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598394686 PECOS PAC ID: 8022433085 Enrollment ID: O20200807000845 |
News Archive
ev3 Inc., a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted for filing the company's Pre-Market Approval (PMA) application for the Pipeline Embolization Device for treatment of large, giant and wide-necked cerebral aneurysms. The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is May 18, 2010, the date the FDA received ev3's PMA submission.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody.
Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study published in the Journal of Infectious Diseases.
Cardiorespiratory fitness is associated with reduced metabolic syndrome risk among smokers, according to researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Todd Breit, MD 421 Andri Ct, El Dorado Hills, CA 95762-5231 Ph: (916) 969-8370 | Dr Aaron Todd Breit, MD 421 Andri Ct, El Dorado Hills, CA 95762-5231 Ph: (916) 969-8370 |
News Archive
ev3 Inc., a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted for filing the company's Pre-Market Approval (PMA) application for the Pipeline Embolization Device for treatment of large, giant and wide-necked cerebral aneurysms. The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is May 18, 2010, the date the FDA received ev3's PMA submission.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody.
Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study published in the Journal of Infectious Diseases.
Cardiorespiratory fitness is associated with reduced metabolic syndrome risk among smokers, according to researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
› Verified 1 days ago
Dr. Xavier Salinas, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5090 Da Vinci Dr, El Dorado Hills, CA 95762 Phone: 916-673-9392 |